- Library Home /
- Search Collections /
- Open Collections /
- Browse Collections /
- UBC Faculty Research and Publications /
- Clinical Experience with Octagam® 10 %, a solvent detergent...
Open Collections
UBC Faculty Research and Publications
Clinical Experience with Octagam® 10 %, a solvent detergent virus inactivated intravenous immunoglobulin: a Canadian retrospective review of utilization Betschel, Stephen D; Warrington, Richard J; Schellenberg, Robert
Abstract
In Canada, intravenous immune globulin (IVIg) products are licensed for six disease indications, however it has been demonstrated that patients with a number of other conditions also benefit from IVIg. Here we report the routine clinical use of Octagam® 10 % across three Canadian institutions. A total of 135 patients were treated with Octagam®, for conditions represented by five distinct indication groups. The results of this review indicate that Octagam® has been well adopted and is prescribed to Canadian patients similar to other IVIg products. In alignment with current practices, 85 % of Octagam’s utilization was classified as appropriate based on Canadian IVIg guidelines.
Item Metadata
| Title |
Clinical Experience with Octagam® 10 %, a solvent detergent virus inactivated intravenous immunoglobulin: a Canadian retrospective review of utilization
|
| Creator | |
| Contributor | |
| Publisher |
BioMed Central
|
| Date Issued |
2016-07-27
|
| Description |
In Canada, intravenous immune globulin (IVIg) products are licensed for six disease indications, however it has been demonstrated that patients with a number of other conditions also benefit from IVIg. Here we report the routine clinical use of Octagam® 10 % across three Canadian institutions. A total of 135 patients were treated with Octagam®, for conditions represented by five distinct indication groups. The results of this review indicate that Octagam® has been well adopted and is prescribed to Canadian patients similar to other IVIg products. In alignment with current practices, 85 % of Octagam’s utilization was classified as appropriate based on Canadian IVIg guidelines.
|
| Subject | |
| Genre | |
| Type | |
| Language |
eng
|
| Date Available |
2017-05-04
|
| Provider |
Vancouver : University of British Columbia Library
|
| Rights |
Attribution 4.0 International (CC BY 4.0)
|
| DOI |
10.14288/1.0347307
|
| URI | |
| Affiliation | |
| Citation |
Allergy, Asthma & Clinical Immunology. 2016 Jul 27;12(1):32
|
| Publisher DOI |
10.1186/s13223-016-0138-9
|
| Peer Review Status |
Reviewed
|
| Scholarly Level |
Faculty
|
| Copyright Holder |
The Author(s)
|
| Rights URI | |
| Aggregated Source Repository |
DSpace
|
Item Media
Item Citations and Data
Rights
Attribution 4.0 International (CC BY 4.0)